Register by August 14 to get the lowest rates for the AACR Conference on Pancreatic Cancer (Sept 25-28; San Diego), chaired by Andrew J. Aguirre, Florencia McAllister, Kenneth P. Olive, Eileen O’Reilly, Diane M. Simeone, and Colin D. Weekes. buff.ly/5NxkGMm #AACRpan26

Young adult cancer patients are not offered palliative care, many people are unaware that removing the fallopian tubes can reduce ovarian cancer risk, and more news from this week in Cancer Today magazine. buff.ly/2JLjvB1

The Week in Cancer News: Young Adult Palliative Care | Cancer Today

Palliative care is underused in young adults with cancer, and a campaign to raise awareness about the fallopian tubes’ role in ovarian cancer.

cancertodaymag.org

In July, the Editors' Picks for AACR’s 10 peer-reviewed journals spotlight studies on an AI program for pancreatic cancer evolution, sex differences in immune responses, a new subset of cells that promotes brain metastasis, and more. Learn more on the #AACRBlog:

Editors’ Picks, July 2026: AI-powered Pancreatic Proteomics, Sex-based Immune Differences, and More

In July 2026, AACR's journals editors highlighted studies on using AI to map pancreatic cancer, sex differences in immune responses and more.

buff.ly

Wired for Innervation: Modeling the Neural Niche in PDAC— Eileen Carpenter will address this topic in a Rising Star Keynote at the AACR Conference on Pancreatic Cancer: New Frontiers in Biology and Therapeutic Development (September 25-28; San Diego). Learn more: buff.ly/YW76Yfy #AACRpan26

What is CAR T-cell therapy? Learn how this innovative immunotherapy targets cancer and which types of cancer it is currently approved to treat on the #AACRBlog:

What Is CAR T-cell Therapy?

An explanation of what is CAR T-cell therapy, how it works, what cancers it is approved to treat, and other commonly asked questions.

buff.ly

Register by August 11 to get the lowest rates for the AACR Special Conference on Pediatric Cancer (September 22-25; Philadelphia), chaired by Olivier Delattre, Annie A. Huang, David M. Langenau, and Suzanne P. MacFarland. Learn more: buff.ly/j4aAdBW #AACRpediatric26

Some pediatric leukemia patients with no evidence of disease after chemotherapy may not need total body irradiation before a stem cell transplant. Learn more in Cancer Today magazine: www.cancertodaymag.org/summer-2026/...

A Gentler Conditioning Regimen for Leukemia  | Cancer Today

Children and young adults with no evidence of acute lymphoblastic leukemia after chemotherapy may be able to avoid radiation prior to stem cell transplantation.

cancertodaymag.org

Register by August 14 to get the lowest rates for the AACR Conference on Pancreatic Cancer (Sept 25-28; San Diego), chaired by Andrew J. Aguirre, Florencia McAllister, Kenneth P. Olive, Eileen O’Reilly, Diane M. Simeone, and Colin D. Weekes. buff.ly/5NxkGMm #AACRpan26

A novel vaccine may intercept pancreatic cancer, and people diagnosed in the emergency department may have a higher mortality rate. Read about this and more in Cancer Today magazine's Week in Cancer News. www.cancertodaymag.org/cancer-talk/...

David Puleo, Marina Nelen, Chinatsu Sakata, and Ryan Potts discussed "Degraders in the Era of Precision Oncology" in an #AACRdrugdev26 plenary session chaired by Danette Daniels. @danetteldaniels.bsky.social @pottslab.bsky.social

Nobel Laureate and #AACRFellows William G. Kaelin discussed "Genetics as the Rosetta Stone for Cancer Therapeutics" in a keynote lecture at the AACR Conference on Drug Discovery and Development. #AACRdrugdev26

Elizabeth Jaffee, Jayesh Desai, Sarah Goldberg, Anthony Joshua, Anirban Maitra, and Puja Sapra discussed "Accelerating Investigator-Initiated Clinical Trials with Team Science" during a special session at #AACRdrugdev26. @anirbanmaitra.bsky.social

AI in Oncology: Facts and Hopes— Sarah Skerratt, Jorge Reis-Filho, and Benjamin Haibe-Kains addressed this topic in a plenary session at the AACR Conference on Drug Discovery and Development. #AACRdrugdev26 @bhaibeka.bsky.social

#AACRFellows William Sellers discussed “Therapeutic Resistance as a Path to Combination Therapy” in a keynote lecture during the AACR Conference on Drug Discovery and Development. #AACRdrugdev26

Poster presenters shared their work with attendees Wednesday evening during the AACR Conference on Drug Discovery and Development. The meeting continues through Friday in Boston. #AACRdrugdev26

Challenges in Drug Discovery: Chemistry— Kevan Shokat, Kyle Seamon, Nina Ilic-Widlund, and Jonathan Levine discussed this topic in a session at the AACR Conference on Drug Discovery and Development. #AACRdrugdev26

Challenges in Drug Discovery: Biology— Paul Workman, Jason M. Sheltzer, Na Zhang, and Eric Spinetti addressed this topic in a session at the AACR Conference on Drug Discovery and Development. #AACRdrugdev26

Stage 4 synovial sarcoma survivor, Reiki practitioner, and yoga teacher Julie Kramer joined the Believe in Progress Podcast. During #SarcomaAwarenessMonth, listen to this inspirational conversation about the power of support during a cancer battle: www.youtube.com/watch?v=IqII...

023: Julie Kramer: Resilience and Holistic Healing

YouTube video by American Association for Cancer Research

youtube.com

RAS Inhibition: Response, Resistance, and Rational Combinations— Kenneth P. Olive, Nilofer Azad, and Rosalie Sears will address this topic in a plenary session at the AACR Conference on Pancreatic Cancer (September 25-28; San Diego). buff.ly/UP32Y2t #AACRpan26 @kenolivelab.bsky.social

Technologies, Biomarkers, and Advanced Diagnostics to Guide Target Discovery and Anticancer Therapies: Maximilian Diehn, Kellie Smith, Issam El Naqa, and Yu Shyr addressed this topic in an #AACRdrugdev26 plenary chaired by Kurt Schalper.

Andrew Berens hosted a fireside chat with Richard Pazdur—former FDA CDER director and former long-time head of the FDA Oncology Center of Excellence—to kick off day 2 of the AACR Conference on Drug Discovery and Development in Boston. #AACRdrugdev26

The first full day of the AACR Conference on Drug Discovery and Development begins soon, featuring special sessions on drugging undruggable targets and challenges in drug discovery. #AACRdrugdev26

Alexis Borisy, Chris Boshoff, and David Schenkein joined in a deeply insightful panel discussion to kick off the AACR Conference on Drug Discovery and Development. #AACRdrugdev26

AACR President Keith Flaherty, Past Presidents Lillian Siu and Patricia LoRusso, and Board Member Timothy Yap, the cochairs for the AACR Conference on Drug Discovery and Development scientific committee, welcomed attendees to the #AACRdrugdev26 meeting this evening in Boston.

The AACR Conference on Drug Discovery and Development opens today in Boston with keynote lectures by Alexis Borisy, Chris Boshoff, and David Schenkein. #AACRdrugdev26

At #AACRrarecancers26, AACR Immediate Past President @lilliansiu.bsky.social announced the AACR Rare Cancers Initiative, which aims to centralize resources to deliver rare cancer research progress. Learn more about the new program on the #AACRBlog: www.aacr.org/blog/2026/07...

Register by August 11 to get the lowest rates for the AACR Special Conference on Pediatric Cancer (September 22-25; Philadelphia), chaired by Olivier Delattre, Annie A. Huang, David M. Langenau, and Suzanne P. MacFarland. Learn more: buff.ly/j4aAdBW #AACRpediatric26

#AACRrarecancers26 cochair Taran Gujral adjourned the AACR Special Conference on Breaking Barriers in the Fight Against Rare Cancers. We thank the cochairs, invited speakers, and abstract presenters for their contributions to this groundbreaking program.

Join the AACR and the research community: Tell policymakers to stop this reckless and destructive power grab. buff.ly/YyGIhGb #UnitedByCancerResearch #CancerResearchSavesLives

AACR Legislative Action Center: Your Voice Matters

Directly contact your elected officials about the importance of cancer research, the need for continued funding and the latest lifesaving breakthroughs. In the United States, you can do so by sending…

buff.ly

Patrick Tan, Charles Roberts, and Atsushi Kaneda discussed "Navigating Genomic and Epigenomic Complexity in Rare Cancers" during a plenary session at the AACR Special Conference on Breaking Barriers in the Fight Against Rare Cancers. #AACRrarecancers26